TENX
TENX
NASDAQ · Biotechnology

Tenax Therapeutics Inc

$1.85
+0.04 (+2.21%)
As of Sep 28, 10:25 PM ET ·
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 11 69%
Hold 5 31%
Sell 0 0%
Price Target
Analyst Price Target +1,701.6% upside
Low Target $30.09
Average Target $33.33
High Target $42.13
Current Price $1.85
Current
$1.85
Target
$33.33
$30.09 $33.33 avg $42.13
Scenario Analysis
Bear Case
$30.09
1,526.5%
Low target
Base Case
$33.33
+1,701.6%
Avg target
Bull Case
$42.13
+2,177.3%
High target
Risk/Reward
1.4x
Balanced
Price in Context
52-Week High
$19.40
-90.5% from high
52-Week Low
$1.31
+41.2% from low
Target vs 52W High
$33.33
+71.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%